Cancer Family
Digestive System Neoplasm
CI-CAN-00000012Explore in graph →
Non-malignant4,733 active trials43 approved drugs557 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000012Explore in graph →
Clinical trials
22,059 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02526264 | Evaluation of Quality of Life and Period of Hospitalization by Education(STELLA) | unknown | N/A | 138 | Krankenhaus NordwestOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT04605185 | Donafenib and Toripalimab Combined With TACE in Patients With Unresectable Hepatocellular Carcinoma | unknown | Phase 1 | 18 | Suzhou Zelgen Biopharmaceuticals Co.,LtdINDUSTRY | 1 | Mar 6, 2024 | clinicaltrials |
| NCT05472857 | Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression | unknown | Phase 1 | 30 | Suzhou Immunofoco Biotechnology Co., LtdINDUSTRY | 1 | Mar 6, 2024 | clinicaltrials |
| NCT05870332 | Nationwide Study of Artificial Intelligence in Adenoma Detection for Colonoscopy(NAIAD) | unknown | — | 4,000 | King's College Hospital NHS TrustOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT06225921 | Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas | unknown | Phase 1 | 6 | West China HospitalOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT06294873 | Stool Sample Collection Study | unknown | — | 40 | Innovis LLCINDUSTRY | 1 | Mar 6, 2024 | clinicaltrials |
| NCT02102789 | A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver Metastasis | unknown | Phase 3 | 142 | Yuhong LiOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT04780217 | Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 42 | ImmVira Pharma Co. LtdINDUSTRY | 1 | Mar 4, 2024 | clinicaltrials |
| NCT05124002 | Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma | unknown | Phase 4 | 66 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT05637788 | Artificial Intelligence and Hepatocellular Carcinoma(ARTIHCC) | unknown | — | 535 | Humanitas Clinical and Research CenterOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT06289712 | Evaluation of the Ablation of Hepatic Lesions by Electroporation(EVALHEP) | unknown | — | 50 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT06289803 | The Application of Probe Confocal Laser Endomicroscopy in Pancreatic Tumor Surgery | unknown | N/A | 200 | Fudan UniversityOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT06291779 | Diagnosis of Pancreatic Cancer by Purine Metabolite (Hypoxanthine, Xanthine) in Urine | unknown | — | 120 | Ho-Seong HanOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT04653181 | Preoperative i.v. Iron Substitution in Patients With Colon Cancer(PREFECO) | unknown | N/A | 514 | Helsinki University Central HospitalOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT06165328 | The Comparison Between Computed Tomography and Colonoscope in Detecting Colorectal Tumors in Patients With FIT+(CTOCOCREC) | unknown | — | 241 | Hat Yai Medical Education CenterOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT06280690 | SGM-101 Tumor Targeted Fluorescence Endoscopy in Rectal Polyps With Suspected T1 Adenocarcinoma or High Grade Dysplasia(SGM-T1) | unknown | Phase 2 | 20 | Leiden University Medical CenterOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT06283303 | A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer | unknown | Phase 1 | 8 | China Medical University, ChinaOTHER | 0 | Feb 29, 2024 | clinicaltrials |
| NCT06284746 | Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer | unknown | Phase 2 | 80 | Lin ChenOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT06285019 | Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 65 | Fudan UniversityOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT01917552 | Adjuvant Capecitabine Versus Observation Alone in Curatively Resected Stage IB Gastric Cancer((KCSG ST14-05): CATALYSIS | unknown | Phase 3 | 870 | Asan Medical CenterOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT05531864 | Ultrasound-guided Continuous Low Serratus Anterior Plane Block in Hepatocellular Carcinoma Surgery(RCT) | unknown | N/A | 160 | Liu DiOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06250166 | Feasibility, Acceptability, and Effectiveness of an Individualized Plant-based (iPLANT) Diet Plan in Colorectal Cancer: Mixed Method Embedded Design | unknown | N/A | 92 | National Cancer Institute, MalaysiaOTHER_GOV | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06281860 | Treatment Pleural Carcinosis of Pressurized IntraThoracic Hyperthermic Aerosol Cisplatin Administration(PITHAC) | unknown | Phase 1 | 39 | Dr Jean Yannis PERENTESOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06282120 | Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancer | unknown | — | 30 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT04923620 | Neoadjuvant Cetuximab + Chemotherapy Combined With Short-course Radiotherapy | unknown | — | 51 | Shanghai Minimally Invasive Surgery CenterOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT05122091 | Fruquintinib Plus SOX as Neoadjuvant Therapy for Locally Advanced Gastric Adenocarcinoma | unknown | Phase 2 | 53 | Guangxi Medical UniversityOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT05371223 | Combined Nabpaclitaxel Pressurized IntraPeritoneal Aerosol Chemotherapy With Systemic Nabpaclitaxel-Gemcitabine Chemotherapy for Pancreatic Cancer Peritoneal Metastases(Nab-PIPAC) | unknown | Phase 2 | 38 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT06277453 | Effect of Adjuvant Chemotherapy Cycles on Patients With Node-negative Gastric Cancer Following Neoadjuvant Chemotherapy | unknown | — | 219 | Fujian Medical UniversityOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT06277908 | Postoperative Morbidity and Mortality After Gastric Cancer Surgery(GASTROSTAT) | unknown | — | 700 | P. Herzen Moscow Oncology Research InstituteOTHER_GOV | 1 | Feb 26, 2024 | clinicaltrials |
| NCT06278064 | Exosome-based Liquid Biopsies for Upper Gastrointestinal Cancers Diagnosis | unknown | — | 562 | Beijing Friendship HospitalOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT06278701 | The Effect of Late-evening Snacks on Patients With Primary Hepatocellular Carcinoma After Hepatectomy | unknown | N/A | 106 | DU YaoOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT06075849 | Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent | unknown | Phase 1 | 30 | Panolos BioscienceINDUSTRY | 1 | Feb 23, 2024 | clinicaltrials |
| NCT05178043 | GT90001 Plus Nivolumab in Patients With Advanced Hepatocellular Carcinoma | unknown | Phase 2 | 5 | Suzhou Kintor Pharmaceutical Inc,INDUSTRY | 1 | Feb 22, 2024 | clinicaltrials |
| NCT05279287 | Video Analysis of Errors and Technical Performance Within Minimally Invasive Surgery Short Title: Video Analysis in Minimally Invasive Surgery (VAMIS)(VAMIS) | unknown | — | 100 | The Griffin InstituteOTHER | 1 | Feb 22, 2024 | clinicaltrials |
| NCT04096417 | Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations | unknown | Phase 2 | 14 | Academic and Community Cancer Research UnitedOTHER | 1 | Feb 21, 2024 | clinicaltrials |
| NCT04633512 | Safety and Feasibility of ActivSightTM in Human | unknown | N/A | 67 | Activ SurgicalINDUSTRY | 1 | Feb 21, 2024 | clinicaltrials |
| NCT05591053 | Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans | unknown | N/A | 70 | Activ SurgicalINDUSTRY | 1 | Feb 21, 2024 | clinicaltrials |
| NCT05924997 | Adebrelimab, Camrelizumab Plus Apatinib as First-line Therapy in Patients With Advanced Hepatocellular Carcinoma | unknown | Phase 1 / Phase 2 | 52 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 1 | Feb 21, 2024 | clinicaltrials |
| NCT06269445 | The Efficacy and Safety of Lcaritin Combined With Bevacizumab and FOLFIRI in Treatment of Liver Metastases From Colorectal Cancer | unknown | Phase 4 | 20 | Sir Run Run Shaw HospitalOTHER | 1 | Feb 21, 2024 | clinicaltrials |
| NCT06271109 | Short Term Surgical Outcomes of Anatomical Versus Non Anatomical Laparoscopic Liver Resection for Liver Tumors | unknown | — | 50 | Sohag UniversityOTHER | 1 | Feb 21, 2024 | clinicaltrials |
| NCT03474822 | Plasmodium Immunotherapy for Breast and Liver Cancers | unknown | Phase 1 / Phase 2 | 60 | CAS Lamvac Biotech Co., Ltd.INDUSTRY | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06203587 | Clinical Study of GPA33-specific PET/CT for the Diagnosis of Colorectal Cancer | unknown | N/A | 40 | Huashan HospitalOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06210334 | HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL)(HAI-TL) | unknown | Phase 2 | 54 | Li Xiao WeiOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT06266871 | SOX Combined With Tislelizumab and LDRT for Neoadjuvant Treatment of Locally Advanced Gastric Cancer | unknown | Phase 1 / Phase 2 | 64 | West China HospitalOTHER | 0 | Feb 20, 2024 | clinicaltrials |
| NCT06268106 | Graphic Novel for Patients Undergoing EUS-FNB | unknown | N/A | 50 | The Mediterranean Institute for Transplantation and Advanced Specialized TherapiesOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT03924466 | Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients(VUBAR) | unknown | Phase 2 | 55 | Universitair Ziekenhuis BrusselOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT06148155 | A Study of [68Ga]Ga-NOTA-RG2 PET Imaging in the Diagnosis of Hepatocellular Carcinoma | unknown | N/A | 20 | Huashan HospitalOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT06203613 | Clinical Study of CLDN18.2 PET/CT for Noninvasive Diagnosis of Gastric and Pancreatic Cancer | unknown | N/A | 40 | YiHui GuanOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT06262581 | Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT06251726 | Personalized Medicine in Early Stage Colorectal Cancer: Organ Preservation and Immune Benefit(COLOSAVE) | unknown | — | 310 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Feb 15, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Mar 6, 2024source: clinicaltrials